BillionToOne, Inc. Class A Common Stock vs. CareDx, Inc.
BillionToOne, Inc. Class A Common Stock (BLLN) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| BLLN | CDNA | |
|---|---|---|
| Market Cap | $5.00 billion | $2.81 billion |
| Revenue (TTM) | $397.41 million | — |
| Net Income (TTM) | $37.71 million | — |
BLLN leads on 1 of 1 size & scale factors.
Valuation
| BLLN | CDNA | |
|---|---|---|
| P/E Ratio | 102.83 | — |
| Price / Book | 9.31 | — |
| Price / Sales | 12.58 | — |
BLLN and CDNA split the valuation factors evenly.
Profitability
| BLLN | CDNA | |
|---|---|---|
| Net Margin | 9.49% | — |
| Return on Equity | 7.03% | — |
BLLN and CDNA split the profitability factors evenly.
Risk & Sentiment
| BLLN | CDNA | |
|---|---|---|
| Short Interest | 0.12% | 7.55% |
BLLN leads on 1 of 1 risk & sentiment factors.
Dig deeper: BLLN overview, BLLN financials, CDNA overview, CDNA financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.